Edition:
United Kingdom

Aerie Pharmaceuticals Inc (AERI.OQ)

AERI.OQ on NASDAQ Stock Exchange Global Market

63.95USD
7:41pm BST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$63.95
Open
$64.30
Day's High
$64.30
Day's Low
$63.25
Volume
41,040
Avg. Vol
117,582
52-wk High
$74.75
52-wk Low
$47.05

Select another date:

Tue, May 15 2018

BRIEF-Aerie Pharmaceuticals Submits NDA To U.S. FDA For Roclatantm

* AERIE PHARMACEUTICALS SUBMITS NEW DRUG APPLICATION TO U.S. FOOD AND DRUG ADMINISTRATION FOR ROCLATANTM (NETARSUDIL/LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005%

BRIEF-Aerie Pharmaceuticals Reports Q1 Adjusted Loss Per Share $0.83

* AERIE PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

BRIEF-Aerie Pharmaceuticals Announces U.S. Launch Of Rhopressa 0.02%

* AERIE PHARMACEUTICALS ANNOUNCES U.S. LAUNCH OF RHOPRESSA® (NETARSUDIL OPHTHALMIC SOLUTION) 0.02%

BRIEF-Aerie Pharmaceuticals CEO Vicente Anido's 2017 Total Compensation Was $10.06 Million

* AERIE PHARMACEUTICALS INC SAYS CEO VICENTE ANIDO'S 2017 TOTAL COMPENSATION WAS $10.06 MILLION – SEC FILING Source text for Eikon: (http://bit.ly/2Kn2hS6) Further company coverage:

BRIEF-Aerie Pharmaceuticals Reports Q4 Adjusted Loss Per Share $1.38

* AERIE PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE AND 2018 GUIDANCE

Select another date: